| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |